Your shopping cart is currently empty

WB518 is a potent STAT3 inhibitor. It effectively suppresses STAT3 activity and the expression of keratin 17. By inhibiting STAT3 phosphorylation and keratin 17, WB518 can significantly alleviate imiquimod and TPA-induced psoriasis in animal models.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | WB518 is a potent STAT3 inhibitor. It effectively suppresses STAT3 activity and the expression of keratin 17. By inhibiting STAT3 phosphorylation and keratin 17, WB518 can significantly alleviate imiquimod and TPA-induced psoriasis in animal models. |
| In vitro | WB518 (5-25 μM) significantly reduces the mRNA and protein levels of keratin 17 (K17) in HaCaT cells by inhibiting the phosphorylation of STAT3 Tyr705 (Y705). |
| In vivo | Topical application of WB518 (at doses of 17.5 μg and 35 μg per site, daily for 5 days) alleviates TPA-induced psoriasis-like skin inflammation and significantly improves the phenotypic characteristics in a mouse model of psoriasis. |
| Formula | C20H16BrN5O5S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.